Published in Oncol Rep on February 12, 2013
SET domain-containing Protein 4 (SETD4) is a Newly Identified Cytosolic and Nuclear Lysine Methyltransferase involved in Breast Cancer Cell Proliferation. J Cancer Sci Ther (2013) 0.76
Comparative genomic hybridization analysis of invasive ductal breast carcinomas in the Chinese population. Oncol Lett (2015) 0.75
Molecular portraits of human breast tumours. Nature (2000) 94.14
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A (2003) 34.68
Clonogenic assay of cells in vitro. Nat Protoc (2006) 11.85
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res (2010) 10.90
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol (2009) 9.18
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med (2007) 8.02
Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol (2010) 5.25
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One (2009) 4.62
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med (2010) 4.38
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res (2008) 3.98
Modelling breast cancer: one size does not fit all. Nat Rev Cancer (2007) 3.64
Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet (2001) 3.58
Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res (1990) 2.57
CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res (2005) 2.53
Integrative analysis of genomic aberrations associated with prostate cancer progression. Cancer Res (2007) 2.14
Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol (2004) 2.01
Genetic alterations in breast cancer. Genes Chromosomes Cancer (1995) 1.86
INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol (2011) 1.78
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res (2005) 1.65
Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. Mol Cancer Ther (2006) 1.64
Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. Oncogene (2003) 1.40
A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics (2000) 1.39
CD24 and human carcinoma: tumor biological aspects. Biomed Pharmacother (2005) 1.23
Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma. Clin Cancer Res (2001) 1.11
Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity. Int J Oncol (2006) 1.09
Isolation of High-molecular-weight DNA from Mammalian Cells Using Proteinase K and Phenol. CSH Protoc (2006) 0.98
Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer. Genes Chromosomes Cancer (1998) 0.94
Models of breast cancer: is merging human and animal models the future? Breast Cancer Res (2003) 0.94
The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas. Cancer Genet Cytogenet (1996) 0.89
Establishment, growth and in vivo differentiation of a new clonal human cell line, EM-G3, derived from breast cancer progenitors. Breast Cancer Res Treat (2006) 0.87
Experimental model and immunohistochemical comparison of U87 human glioblastoma cell xenografts on the chicken chorioallantoic membrane and in rat brains. Anticancer Res (2010) 0.87
Loss of heterozygosity at loci from chromosome arm 22Q in human sporadic breast carcinomas. Int J Cancer (1998) 0.85
Establishment and characterization of MACL-1 and MGSO-3 cell lines derived from human primary breast cancer. Oncol Res (2009) 0.80
Glyceraldehyde-3-phosphate dehydrogenase as a surface associated antigen on human breast cancer cell lines MACL-1 and MGSO-3. Oncol Rep (2010) 0.78
Effect of radiation treatment on newly established human breast cancer cell lines MACL-1 and MGSO-3. Tumour Biol (2010) 0.76
Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell (2012) 3.19
Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome. J Clin Oncol (2011) 2.36
The type III inositol 1,4,5-trisphosphate receptor preferentially transmits apoptotic Ca2+ signals into mitochondria. J Biol Chem (2005) 2.00
Insulin induces calcium signals in the nucleus of rat hepatocytes. Hepatology (2008) 1.74
Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile. Gastroenterology (2007) 1.73
VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci U S A (2011) 1.60
The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials (2004) 1.45
CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer (2006) 1.41
Nucleoplasmic calcium is required for cell proliferation. J Biol Chem (2007) 1.34
Digital slides: present status of a tool for consultation, teaching, and quality control in pathology. Pathol Res Pract (2009) 1.29
The ER luminal binding protein (BiP) mediates an increase in drought tolerance in soybean and delays drought-induced leaf senescence in soybean and tobacco. J Exp Bot (2008) 1.22
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients. Breast Cancer Res Treat (2010) 1.19
GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. Clinics (Sao Paulo) (2011) 1.19
Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplant (2009) 1.14
Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression. Oncol Rep (2010) 1.11
Nuclear Ca2+ regulates cardiomyocyte function. Cell Calcium (2008) 1.09
Inheritance of DNA transferred from American trypanosomes to human hosts. PLoS One (2010) 1.07
Selecting antibodies to detect HER2 overexpression by immunohistochemistry in invasive mammary carcinomas. Appl Immunohistochem Mol Morphol (2006) 1.05
The spatial distribution of inositol 1,4,5-trisphosphate receptor isoforms shapes Ca2+ waves. J Biol Chem (2007) 1.05
Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas. Int J Cancer (2006) 1.05
A novel transcription factor, ERD15 (Early Responsive to Dehydration 15), connects endoplasmic reticulum stress with an osmotic stress-induced cell death signal. J Biol Chem (2011) 1.02
Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma. BJU Int (2013) 1.01
Lipid rafts establish calcium waves in hepatocytes. Gastroenterology (2007) 1.01
Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer. Oncogene (2002) 1.01
Down-regulation of the candidate tumor suppressor gene PAR-4 is associated with poor prognosis in breast cancer. Int J Oncol (2010) 1.00
Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication. Hum Pathol (2010) 0.99
Succinate modulates Ca(2+) transient and cardiomyocyte viability through PKA-dependent pathway. Cell Calcium (2009) 0.98
Independent clonal origin of multiple uterine leiomyomas that was determined by X chromosome inactivation and microsatellite analysis. Am J Obstet Gynecol (2005) 0.98
Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas. Clinics (Sao Paulo) (2012) 0.98
Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation. Endocr Relat Cancer (2013) 0.96
Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment. Pituitary (2009) 0.96
Immunohistochemical expression of estrogen receptor in enlarged lobular units with columnar alteration in benign breast biopsies: a nested case-control study. Am J Surg Pathol (2005) 0.95
Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers. Hum Pathol (2008) 0.95
Molecular basis for pacemaker cells in epithelia. J Biol Chem (2002) 0.95
A comparative study between mixed-type tumours from human salivary and canine mammary glands. BMC Cancer (2007) 0.94
Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers. Pathology (2012) 0.94
Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma. Clin Endocrinol (Oxf) (2012) 0.94
Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus. Int J Gynecol Pathol (2005) 0.94
Immunohistochemical expression of p63 in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands. Oral Oncol (2005) 0.93
Cytosolic calcium regulates liver regeneration in the rat. Hepatology (2010) 0.93
Epidermal growth factor receptors destined for the nucleus are internalized via a clathrin-dependent pathway. Biochem Biophys Res Commun (2011) 0.93
Stem cells and calcium signaling. Adv Exp Med Biol (2012) 0.92
Endothelial differentiation of human stem cells seeded onto electrospun polyhydroxybutyrate/polyhydroxybutyrate-co-hydroxyvalerate fiber mesh. PLoS One (2012) 0.92
Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma. Cancer Chemother Pharmacol (2009) 0.91
DAPI diffusion after intravitreal injection of mesenchymal stem cells in the injured retina of rats. Cell Transplant (2009) 0.91
Leukotriene B4 creates a favorable microenvironment for murine melanoma growth. Mol Cancer Res (2009) 0.90
A comparision of aspiration cytology and core needle biopsy according to tumor size of suspicious breast lesions. Diagn Cytopathol (2008) 0.89
Apoptotic cells contribute to melanoma progression and this effect is partially mediated by the platelet-activating factor receptor. Mediators Inflamm (2012) 0.89
Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis. BMC Cancer (2008) 0.89
A transcript finishing initiative for closing gaps in the human transcriptome. Genome Res (2004) 0.89
A comparison between manual and automated evaluations of tissue microarray patterns of protein expression. J Histochem Cytochem (2013) 0.88
Hormonal regulation of nuclear permeability. J Biol Chem (2006) 0.88
Ovarian mucinous cystadenoma in a gray brocket deer (Mazama gouazoupira). J Vet Diagn Invest (2011) 0.87
[Immunophenotype and evolution of breast carcinomas: a comparison between very young and postmenopausal women]. Rev Bras Ginecol Obstet (2009) 0.87
Three-dimensional culture of rat BMMSCs in a porous chitosan-gelatin scaffold: A promising association for bone tissue engineering in oral reconstruction. Arch Oral Biol (2011) 0.87
Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis. J Oral Pathol Med (2003) 0.86
Pruritic papular eruption and eosinophilic folliculitis associated with human immunodeficiency virus (HIV) infection: a histopathological and immunohistochemical comparative study. J Am Acad Dermatol (2012) 0.86
Evaluation of the influence of polymorphic variants CYP1A1 2B, CYP1B1 2, CYP3A4 1B, GSTM1 0, and GSTT1 0 in prostate cancer. Urol Oncol (2010) 0.86
Effect of a three-dimensional chitosan porous scaffold on the differentiation of mesenchymal stem cells into chondrocytes. Cells Tissues Organs (2009) 0.85
Activation of the Wnt/beta-catenin signaling pathway during oral carcinogenesis process is not influenced by the absence of galectin-3 in mice. Anticancer Res (2011) 0.85
Overexpression of Fos-related antigen-1 in head and neck squamous cell carcinoma. Int J Exp Pathol (2005) 0.85
Infiltration of a mixture of different immune cells may be related to molecular profile of differentiated thyroid cancer. Endocr Relat Cancer (2012) 0.85
Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages. Cancer Med (2014) 0.85
MGMT and PTEN as potential prognostic markers in breast cancer. Exp Mol Pathol (2011) 0.85
Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital--a closer look into cause-specific mortality. BMC Cancer (2013) 0.85
Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome. J Rheumatol (2007) 0.85
Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction. J Cell Mol Med (2013) 0.85
Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer. Clin Exp Med (2008) 0.84
Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture. BMC Cancer (2013) 0.84
Evaluation of reliability of FISH versus brightfield dual-probe in situ hybridization (BDISH) for frontline assessment of HER2 status in breast cancer samples in a community setting: influence of poor tissue preservation. Am J Surg Pathol (2012) 0.84
Evaluation of estrogen receptor alpha, estrogen receptor beta, progesterone receptor, and cKIT expression in desmoids tumors and their role in determining treatment options. Biosci Trends (2010) 0.84
Expression of PCNA, p53, Bax, and Bcl-X in oral poorly differentiated and basaloid squamous cell carcinoma: relationships with prognosis. Head Neck (2005) 0.84
Protective effect and granuloma down-modulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni. Immunobiology (2007) 0.84
Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance. Anticancer Res (2013) 0.84
Biological applications of a chimeric probe for the assessment of galectin-3 ligands. J Histochem Cytochem (2007) 0.84
DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas? Mol Carcinog (2005) 0.84
Oral vaccination based on DNA-chitosan nanoparticles against Schistosoma mansoni infection. ScientificWorldJournal (2012) 0.83
The combined use of Paracoccidioides brasiliensis Pb40 and Pb27 recombinant proteins enhances chemotherapy effects in experimental paracoccidioidomycosis. Microbes Infect (2011) 0.83
Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population. Anticancer Res (2008) 0.83
Lobular neoplasia: frequency and association with other breast lesions. Diagn Pathol (2011) 0.83
Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma. Cancer Biomark (2012) 0.83
C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer. Oncol Rep (2007) 0.83
Vulvar cancer surgery. Curr Opin Obstet Gynecol (2014) 0.83
Primary and secondary angiosarcomas of the breast: a single institution experience. Breast Cancer Res Treat (2011) 0.83
Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas. Cancer Detect Prev (2004) 0.83
[Morbidity after sentinel node biopsy and axillary dissection in breast cancer]. Rev Assoc Med Bras (2009) 0.83
[Evaluation of breast microcalcifications according to Breast Imaging Reporting and Data System (BI-RADS) and Le Gal's classifications]. Rev Bras Ginecol Obstet (2008) 0.82
P53 and Rb tumor suppressor gene alterations in gastric cancer. Rev Hosp Clin Fac Med Sao Paulo (2004) 0.82
E-cadherin abnormalities resulting from CPG methylation promoter in metastatic and nonmetastatic oral cancer. Head Neck (2008) 0.82
STEAP1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinoma. Histopathology (2013) 0.82
[Basal-like breast cancers: clinicopathological features and outcome]. Rev Assoc Med Bras (2009) 0.82
Additive effect of rPb27 immunization and chemotherapy in experimental paracoccidioidomycosis. PLoS One (2011) 0.82
Oral carcinoma epidemiology in Paraná State, Southern Brazil. Cad Saude Publica (2009) 0.82
DNA methylation patterns of the CDH1, RARB, and SFN genes in choroid plexus tumors. Cancer Genet Cytogenet (2007) 0.82